During the past decade, Marien-Hospital Witten conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marien-Hospital Witten" #1 sponsor was "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials, followed by "Arcagy Research" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Fondazione Michelangelo" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marien-Hospital Witten" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom Germany" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Marien-Hospital Witten" are "Breast Cancer" (3 trials), "Cholangiocarcinoma" (2 trials), "Gallbladder Cancer" (2 trials), "Hepatocellular Cancer" (2 trials) and "Oesophageal Cancer" (2 trials). Many other conditions were trialed in "Marien-Hospital Witten" in a lesser frequency.

Most popular intervention types in "Marien-Hospital Witten" are "Drug" (9 trials), "Procedure" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marien-Hospital Witten" are 9 trials for "Female" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "Marien-Hospital Witten". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Marien-Hospital Witten, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marien-Hospital Witten, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".